Champions Oncology, Inc. (CSBR) Debt to Equity Ratio
Champions Oncology, Inc. (CSBR) debt-to-equity ratio history and balance sheet leverage. Analyze D/E ratio in Excel with MarketXLS.
Debt to Equity Ratio Data
| Period | Debt/Equity |
|---|---|
| 2018-04-30 | 14.33 |
| 2019-04-30 | 1.86 |
| 2020-04-30 | 0.74 |
| 2021-04-30 | 1.29 |
| 2022-04-30 | 1.05 |
| 2023-04-30 | 1.86 |
| 2025-04-30 | 1.62 |
| 2026-04-30 | 1.11 |
Debt to equity divides total borrowings by total shareholder equity at the period end. Total borrowings are short-term debt plus long-term debt, including capital lease obligations. Non-debt liabilities such as accounts payable and deferred revenue are excluded. A period is omitted when equity is negative, because the ratio is not meaningful then.
Get Champions Oncology, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Debt_to_Equity_Ratio("CSBR", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CSBR | $5.07 | +0.00% | 0.01M |
| 3 | ||||
| 4 | ||||
| 5 |